Evogene (EVGN) Competitors $1.38 -0.01 (-0.36%) Closing price 03:39 PM EasternExtended Trading$1.44 +0.06 (+4.65%) As of 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends EVGN vs. ENFY, TOMZ, BSLK, GURE, NITO, DNMR, SNES, CNEY, TANH, and GAMCWShould you be buying Evogene stock or one of its competitors? The main competitors of Evogene include Enlightify (ENFY), TOMI Environmental Solutions (TOMZ), Bolt Projects (BSLK), Gulf Resources (GURE), N2OFF (NITO), Danimer Scientific (DNMR), SenesTech (SNES), CN Energy Group. (CNEY), Tantech (TANH), and Golden Arrow Merger (GAMCW). These companies are all part of the "chemicals" industry. Evogene vs. Enlightify TOMI Environmental Solutions Bolt Projects Gulf Resources N2OFF Danimer Scientific SenesTech CN Energy Group. Tantech Golden Arrow Merger Enlightify (NYSE:ENFY) and Evogene (NASDAQ:EVGN) are both small-cap basic materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, media sentiment, analyst recommendations, institutional ownership, profitability and community ranking. Which has better valuation and earnings, ENFY or EVGN? Evogene has lower revenue, but higher earnings than Enlightify. Enlightify is trading at a lower price-to-earnings ratio than Evogene, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnlightify$87.36M0.18-$28.41M-$1.98-0.55Evogene$8.51M0.87-$23.88M-$3.11-0.45 Do insiders and institutionals have more ownership in ENFY or EVGN? 0.1% of Enlightify shares are held by institutional investors. Comparatively, 10.4% of Evogene shares are held by institutional investors. 38.2% of Enlightify shares are held by insiders. Comparatively, 7.4% of Evogene shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the MarketBeat Community favor ENFY or EVGN? Evogene received 221 more outperform votes than Enlightify when rated by MarketBeat users. CompanyUnderperformOutperformEnlightifyN/AN/AEvogeneOutperform Votes22154.03% Underperform Votes18845.97% Does the media prefer ENFY or EVGN? In the previous week, Evogene had 1 more articles in the media than Enlightify. MarketBeat recorded 1 mentions for Evogene and 0 mentions for Enlightify. Enlightify's average media sentiment score of 0.00 equaled Evogene'saverage media sentiment score. Company Overall Sentiment Enlightify Neutral Evogene Neutral Do analysts rate ENFY or EVGN? Evogene has a consensus price target of $12.00, suggesting a potential upside of 765.80%. Given Evogene's stronger consensus rating and higher probable upside, analysts plainly believe Evogene is more favorable than Enlightify.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Enlightify 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Evogene 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility & risk, ENFY or EVGN? Enlightify has a beta of 0.6, suggesting that its stock price is 40% less volatile than the S&P 500. Comparatively, Evogene has a beta of 1.28, suggesting that its stock price is 28% more volatile than the S&P 500. Is ENFY or EVGN more profitable? Enlightify has a net margin of -31.34% compared to Evogene's net margin of -314.43%. Enlightify's return on equity of -26.06% beat Evogene's return on equity.Company Net Margins Return on Equity Return on Assets Enlightify-31.34% -26.06% -16.39% Evogene -314.43%-109.05%-52.55% SummaryEvogene beats Enlightify on 10 of the 16 factors compared between the two stocks. Remove Ads Get Evogene News Delivered to You Automatically Sign up to receive the latest news and ratings for EVGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EVGN vs. The Competition Export to ExcelMetricEvogeneAgricultural chemicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.44M$4.35B$5.72B$8.09BDividend YieldN/A3.98%4.41%4.08%P/E Ratio-0.3135.8824.1518.97Price / Sales0.873.98394.1189.89Price / CashN/A7.3138.1134.64Price / Book0.200.946.934.35Net Income-$23.88M$314.10M$3.18B$246.92M7 Day Performance-3.08%0.23%1.05%1.35%1 Month Performance-2.19%-9.41%1.67%-6.52%1 Year Performance-82.34%-40.58%14.41%3.35% Evogene Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EVGNEvogene1.4544 of 5 stars$1.38-0.4%$12.00+772.7%-82.7%$7.38M$8.51M-0.31140Analyst ForecastENFYEnlightifyN/A$1.12-0.9%N/AN/A$16.18M$87.36M-0.55424Gap DownTOMZTOMI Environmental Solutions2.9939 of 5 stars$0.78-6.0%$3.50+348.7%+12.2%$15.61M$8.20M-6.0020News CoverageGap UpBSLKBolt ProjectsN/A$0.34-8.7%N/AN/A$11.61M$2.15M0.0012Earnings ReportNews CoverageGap DownGUREGulf Resources0.2076 of 5 stars$0.72-1.4%N/A-37.3%$7.72M$12.80M-0.08420Short Interest ↑NITON2OFF1.3518 of 5 stars$0.29-3.3%N/AN/A$4.45M$175,308.000.002Short Interest ↓Positive NewsGap DownDNMRDanimer Scientific0.9683 of 5 stars$1.11-1.8%$13.83+1,146.2%-99.4%$3.35M$37.43M-0.03280Upcoming EarningsNews CoverageGap DownSNESSenesTech2.0394 of 5 stars$2.35-21.9%$10.00+325.5%-70.8%$2.43M$1.65M0.0030Gap DownHigh Trading VolumeCNEYCN Energy Group.0.1009 of 5 stars$0.17-5.6%N/A-84.6%$1.20M$50.96M0.00160Gap DownTANHTantech0.1009 of 5 stars$2.87-5.3%N/A-90.9%$273,000.00$49.10M0.0070GAMCWGolden Arrow MergerN/A$0.04flatN/AN/A$0.00N/A0.0012 Remove Ads Related Companies and Tools Related Companies ENFY Competitors TOMZ Competitors BSLK Competitors GURE Competitors NITO Competitors DNMR Competitors SNES Competitors CNEY Competitors TANH Competitors GAMCW Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EVGN) was last updated on 3/21/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evogene Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evogene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.